Familial localized heat urticaria of delayed type.
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D000937:Antigen-Antibody Reactions; D001285:Atropine / Q000494:pharmacology / Q000627:therapeutic use; D001491:Basophils / Q000378:metabolism; D001706:Biopsy; D001920:Bradykinin / Q000494:pharmacology; D002648:Child; D005260:Female; D006632:Histamine / Q000378:metabolism*; D006634:Histamine H1 Antagonists / Q000494:pharmacology / Q000627:therapeutic use; D006358:Hot Temperature; D006801:Humans; D006968:Hypersensitivity, Delayed; D007609:Kallidin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D007610:Kallikreins / Q000494:pharmacology; D007958:Leukocyte Count; D008012:Lidocaine / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008688:Methacholine Compounds / Q000494:pharmacology; D008875:Middle Aged; D010375:Pedigree; D011453:Prostaglandins / Q000494:pharmacology; D012698:Serologic Tests; D012881:Skin Temperature; D012882:Skin Tests; D014581:Urticaria / Q000175:diagnosis / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D003189:p-Methoxy-N-methylphenethylamine / Q000494:pharmacology / Q000627:therapeutic use*
D006634:Histamine H1 Antagonists; D008688:Methacholine Compounds; D011453:Prostaglandins; D007609:Kallidin; D003189:p-Methoxy-N-methylphenethylamine; D001285:Atropine; D006632:Histamine; D008012:Lidocaine; D007610:Kallikreins; D000109:Acetylcholine; D001920:Bradykinin